A Randomized Phase Ii Study Comparing Cabazitaxel/Prednisone To Cabazitaxel Alone In Docetaxel-Pretreated Men With Metastatic Castration Resistant Prostate Cancer (Mcrpc): The Cabacare Trial.
JOURNAL OF CLINICAL ONCOLOGY(2019)
Abstract
TPS345Background: In the TROPIC trial, cabazitaxel (CAB) plus daily prednisone (PDN) was associated with a significant advantage in OS and PFS in docetaxel (DOC)-pretreated patients (Pts). Whether ...
MoreTranslated text
Key words
resistant prostate cancer,prostate cancer,cabazitaxel/prednisone,docetaxel-pretreated
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined